Whole Exome Sequencing Market Report
RA01918
Whole Exome Sequencing Market, by Product (Services, Consumables, Instruments), Application (Diagnostics, Drug Discovery and Development, Personalized Medicine, Agriculture & Animal Research, Others), End Use (Hospitals, Clinics, Research Centers, Academic & Government Institutes, Pharmaceutical & Biotechnology Companies, Others), Technology (Sequencing by Synthesis (SBS), ION Semiconductor Sequencing, Other Technologies): Global Opportunity Analysis and Industry Forecast, 2020-2027
The global whole exome sequencing market is estimated to surpass $6,436.5 million by 2027, exhibiting a CAGR of 22.0% from 2020 to 2027.
The report provides all-inclusive analysis of global whole exome sequencing market with comprehensive study of the various facets of the market including market dynamics, major segments and regions, top leading players, and competitive landscape.
The report emphasizes current market scenario and future trends of the global whole exome sequencing market which gleaned from the impact of various market dynamics such as drivers, challenges & restraints, lucrative opportunities. The report also highlights the key forces that are shaping the market. Besides, the report provides Porter’s five forces analysis which precisely underlines the impact of key forces on the global whole exome sequencing market.
In addition, the report provides market size and forecast scrutinizing global whole exome sequencing market through different segments. The report highlights the geographical market analysis of these segments and each segment is thoroughly studied at regional as well as country level to get clearer picture of the global whole exome sequencing market. In the report, the global whole exome sequencing market is divided into four major regions including North America, Europe, Asia-Pacific, and LAMEA. These regions are further divided into major countries to cover whole exome sequencing market landscape in respective regions.
Furthermore, competitive scenario of the global whole exome sequencing market is covered in the report. Major players functioning in the global whole exome sequencing market are also studied to understand their position and competitive strengths in the industry. The major company profiles covered in the report include various company’s datum such as brief overview, recent financials, main executives, adoption of key growth strategies, novel advancements or initiatives to sustain and expand their position in the global whole exome sequencing market, and others.
Research Methodology
Research Dive offers its clients extensive research and analysis gleaned from wide variety of factual inputs that largely includes interview with participants of the industry, reliable data & statistics, and regional intelligence. The in-house experts of the industry play a crucial role in designing analytic tools and models, tailor-made to the requests of an industry segment. The data and statistics are sterilized with these analytical tools and models, which enhances the accuracy of our advice and recommendations.
This research report is delivered by Research Dive by conducting long hours of discussions and interviews, with a broad range of stakeholders, which includes upstream and downstream participants. Our analysts have performed a mix of primary and secondary research for the market estimations and forecasts. A number of product type literatures, industry releases, annual reports, and other related documents of major participants of the industry have been reviewed, to better understand the global whole exome sequencing market scenario. The initial phase of our in-depth study, where we perform wide-range data mining, referring to proficient & verified data sources such as independent studies, medical journals, technical journals, releases by trade association, materials published by government & regulatory authorities, and other.
KEY MARKET BENEFITS
- This report is a compilation of detailed study, information, valid inputs from industry experts & industry participants across the value chain, and quantitative & qualitative assessment by analysts of the industry.
- The report provides a comprehensive analysis along with the current trends of market during the forecast period from 2019 to 2027 to identify & comprehend the prevailing opportunities and the strategic assessment of the global whole exome sequencing market growth.
- The report studies the market from 2019 to 2027 and maps the qualitative impact of several industry factors on market segments as well as geographies.
- The report provides market estimations and size which is based on in-depth analysis of recent & key developments in the whole exome sequencing market.
- The development strategies implemented by the key industry players are conscripted in the report to understand the competitive scenario of the global whole exome sequencing market.
KEY MARKET SEGMENTS
The market has been studied based on the following segments:
- Product: Services, Consumables, Instruments
- Application: Diagnostics, Drug Discovery and Development, Personalized Medicine, Agriculture & Animal Research, Others
- End Use: Hospitals, Clinics, Research Centers, Academic & Government Institutes, Pharmaceutical & Biotechnology Companies, Others
- Technology: Sequencing by Synthesis (SBS), ION Semiconductor Sequencing, Other Technologies
Region:
The global whole exome sequencing market is divided into North America, Europe, Asia Pacific, and LAMEA.
The above-mentioned regions are further dived in countries as follows:
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Argentina
- Saudi Arabia
- South Africa
- UAE
- Rest of LAMEA
KEY MARKET PLAYERS
The report covers the major players operating in the global whole exome sequencing market that focus on advancements & innovations and geographical expansion of product portfolios to obtain a competitive edge in the market space. The major players enlisted in the report include GENEWIZ, Inc., Ambry Genetics, Inc., Inc., …., and others.
The report summarizes various aspects of all these key players that include as follows:
1. Macrogen, Inc.
2. Ambry Genetics
3. Illumina
4. Inc.
5. Knome, Inc.
6. Life Technologies
7. Agilent Technologies
8. Roche NimbleGen, Inc.
9. Sengenics
10. GENEWIZ, Inc.
11. Eurofins Genomics
12. Inc.
13. BGI
-
1. RESEARCH METHODOLOGY
1.1. Desk Research
1.2. Real time insights and validation
1.3. Forecast model
1.4. Assumptions and forecast parameters
1.5. Market size estimation
1.5.1. Top-down approach
1.5.2. Bottom-up approach
-
2. REPORT SCOPE
2.1. Market definition
2.2. Key objectives of the study
2.3. Report overview
2.4. Market segmentation
2.5. Overview of the impact of COVID-19 on Global Whole Exome Sequencing Market
-
3. EXECUTIVE SUMMARY
-
4. MARKET OVERVIEW
4.1. Introduction
4.2. Growth impact forces
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.3. Market value chain analysis
4.3.1. List of raw material suppliers
4.3.2. List of manufacturers
4.3.3. List of distributors
4.4. Innovation & sustainability matrices
4.4.1. Technology matrix
4.4.2. Regulatory matrix
4.5. Porter’s five forces analysis
4.5.1. Bargaining power of suppliers
4.5.2. Bargaining power of consumers
4.5.3. Threat of substitutes
4.5.4. Threat of new entrants
4.5.5. Competitive rivalry intensity
4.6. PESTLE analysis
4.6.1. Political
4.6.2. Economical
4.6.3. Social
4.6.4. Technological
4.6.5. Environmental
4.7. Impact of COVID-19 on Whole Exome Sequencing Market
4.7.1. Pre-covid market scenario
4.7.2. Post-covid market scenario
-
5. Whole Exome Sequencing Market, By Product
5.1. Overview
5.2 Services
5.2.1 Definition, key trends, growth factors, and opportunities
5.2.2 Market size analysis, by region, 2020-2027
5.2.3 Market share analysis, by country, 2020-2027
5.3 Consumables
5.3.1 Definition, key trends, growth factors, and opportunities
5.3.2 Market size analysis, by region, 2020-2027
5.3.3 Market share analysis, by country, 2020-2027
5.4 Instruments
5.4.1 Definition, key trends, growth factors, and opportunities
5.4.2 Market size analysis, by region, 2020-2027
5.4.3 Market share analysis, by country, 2020-2027
5.5 Research Dive Exclusive Insights
5.5.1 Market attractiveness
5.5.2 Competition heatmap
-
6. Whole Exome Sequencing Market, By Technology
6.1. Overview
6.2 Diagnostics
6.2.1 Definition, key trends, growth factors, and opportunities
6.2.2 Market size analysis, by region, 2020-2027
6.2.3 Market share analysis, by country, 2020-2027
6.3 Drug Discovery and Development
6.3.1 Definition, key trends, growth factors, and opportunities
6.3.2 Market size analysis, by region, 2020-2027
6.3.3 Market share analysis, by country, 2020-2027
6.4 Personalized Medicine
6.4.1 Definition, key trends, growth factors, and opportunities
6.4.2 Market size analysis, by region, 2020-2027
6.4.3 Market share analysis, by country, 2020-2027
6.5 Agriculture & Animal Research
6.5.1 Definition, key trends, growth factors, and opportunities
6.5.2 Market size analysis, by region, 2020-2027
6.5.3 Market share analysis, by country, 2020-2027
6.6 Others
6.6.1 Definition, key trends, growth factors, and opportunities
6.6.2 Market size analysis, by region, 2020-2027
6.6.3 Market share analysis, by country, 2020-2027
6.7 Research Dive Exclusive Insights
6.7.1 Market attractiveness
6.7.2 Competition heatmap
-
7. Whole Exome Sequencing Market, By Distribution Channel
7.1. Overview
7.2 Hospitals
7.2.1 Definition, key trends, growth factors, and opportunities
7.2.2 Market size analysis, by region, 2020-2027
7.2.3 Market share analysis, by country, 2020-2027
7.3 Clinics
7.3.1 Definition, key trends, growth factors, and opportunities
7.3.2 Market size analysis, by region, 2020-2027
7.3.3 Market share analysis, by country, 2020-2027
7.4 Research Centers
7.4.1 Definition, key trends, growth factors, and opportunities
7.4.2 Market size analysis, by region, 2020-2027
7.4.3 Market share analysis, by country, 2020-2027
7.5 Academic & Government Institutes
7.5.1 Definition, key trends, growth factors, and opportunities
7.5.2 Market size analysis, by region, 2020-2027
7.5.3 Market share analysis, by country, 2020-2027
7.6 Pharmaceutical & Biotechnology Companies
7.6.1 Definition, key trends, growth factors, and opportunities
7.6.2 Market size analysis, by region, 2020-2027
7.6.3 Market share analysis, by country, 2020-2027
7.7 Others
7.7.1 Definition, key trends, growth factors, and opportunities
7.7.2 Market size analysis, by region, 2020-2027
7.7.3 Market share analysis, by country, 2020-2027
7.8 Research Dive Exclusive Insights
7.8.1 Market attractiveness
7.8.2 Competition heatmap
-
8. Whole Exome Sequencing Market, By Atrial Fibrillation Type
8.1. Overview
8.2 Sequencing by Synthesis (SBS)
8.2.1 Definition, key trends, growth factors, and opportunities
8.2.2 Market size analysis, by region, 2020-2027
8.2.3 Market share analysis, by country, 2020-2027
8.3 ION Semiconductor Sequencing
8.3.1 Definition, key trends, growth factors, and opportunities
8.3.2 Market size analysis, by region, 2020-2027
8.3.3 Market share analysis, by country, 2020-2027
8.4 Other Technologies
8.4.1 Definition, key trends, growth factors, and opportunities
8.4.2 Market size analysis, by region, 2020-2027
8.4.3 Market share analysis, by country, 2020-2027
8.5 Research Dive Exclusive Insights
8.5.1 Market attractiveness
8.5.2 Competition heatmap
9. Whole Exome Sequencing Market, By Region
9.1 North America
9.1.1 U.S
9.1.1.1 Market size analysis, By Product, 2020-2027
9.1.1.2 Market size analysis, By Technology, 2020-2027
9.1.1.3 Market size analysis, By Distribution Channel, 2020-2027
9.1.1.4 Market size analysis, By Atrial Fibrillation Type, 2020-2027
9.1.2 Canada
9.1.2.1 Market size analysis, By Product, 2020-2027
9.1.2.2 Market size analysis, By Technology, 2020-2027
9.1.2.3 Market size analysis, By Distribution Channel, 2020-2027
9.1.2.4 Market size analysis, By Atrial Fibrillation Type, 2020-2027
9.1.3 Mexico
9.1.3.1 Market size analysis, By Product, 2020-2027
9.1.3.2 Market size analysis, By Technology, 2020-2027
9.1.3.3 Market size analysis, By Distribution Channel, 2020-2027
9.1.3.4 Market size analysis, By Atrial Fibrillation Type, 2020-2027
9.1.4 Research Dive Exclusive Insights
9.1.4.1 Market attractiveness
9.1.4.2 Competition heatmap
9.2 Europe
9.2.1 Germany
9.2.1.1 Market size analysis, By Product, 2020-2027
9.2.1.2 Market size analysis, By Technology, 2020-2027
9.2.1.3 Market size analysis, By Distribution Channel, 2020-2027
9.2.1.4 Market size analysis, By Atrial Fibrillation Type, 2020-2027
9.2.2 UK
9.2.2.1 Market size analysis, By Product, 2020-2027
9.2.2.2 Market size analysis, By Technology, 2020-2027
9.2.2.3 Market size analysis, By Distribution Channel, 2020-2027
9.2.2.4 Market size analysis, By Atrial Fibrillation Type, 2020-2027
9.2.3 France
9.2.3.1 Market size analysis, By Product, 2020-2027
9.2.3.2 Market size analysis, By Technology, 2020-2027
9.2.3.3 Market size analysis, By Distribution Channel, 2020-2027
9.2.3.4 Market size analysis, By Atrial Fibrillation Type, 2020-2027
9.2.4 Spain
9.2.4.1 Market size analysis, By Product, 2020-2027
9.2.4.2 Market size analysis, By Technology, 2020-2027
9.2.4.3 Market size analysis, By Distribution Channel, 2020-2027
9.2.4.4 Market size analysis, By Atrial Fibrillation Type, 2020-2027
9.2.5 Italy
9.2.5.1 Market size analysis, By Product, 2020-2027
9.2.5.2 Market size analysis, By Technology, 2020-2027
9.2.5.3 Market size analysis, By Distribution Channel, 2020-2027
9.2.5.4 Market size analysis, By Atrial Fibrillation Type, 2020-2027
9.2.6 Rest of Europe
9.2.6.1 Market size analysis, By Product, 2020-2027
9.2.6.2 Market size analysis, By Technology, 2020-2027
9.2.6.3 Market size analysis, By Distribution Channel, 2020-2027
9.2.6.4 Market size analysis, By Atrial Fibrillation Type, 2020-2027
9.2.7 Research Dive Exclusive Insights
9.2.7.1 Market attractiveness
9.2.7.2 Competition heatmap
9.3 Asia-Pacific
9.3.1 China
9.3.1.1 Market size analysis, By Product, 2020-2027
9.3.1.2 Market size analysis, By Technology, 2020-2027
9.3.1.3 Market size analysis, By Distribution Channel, 2020-2027
9.3.1.4 Market size analysis, By Atrial Fibrillation Type, 2020-2027
9.3.2 Japan
9.3.2.1 Market size analysis, By Product, 2020-2027
9.3.2.2 Market size analysis, By Technology, 2020-2027
9.3.2.3 Market size analysis, By Distribution Channel, 2020-2027
9.3.2.4 Market size analysis, By Atrial Fibrillation Type, 2020-2027
9.3.3 India
9.3.3.1 Market size analysis, By Product, 2020-2027
9.3.3.2 Market size analysis, By Technology, 2020-2027
9.3.3.3 Market size analysis, By Distribution Channel, 2020-2027
9.3.3.4 Market size analysis, By Atrial Fibrillation Type, 2020-2027
9.3.4 Australia
9.3.4.1 Market size analysis, By Product, 2020-2027
9.3.4.2 Market size analysis, By Technology, 2020-2027
9.3.4.3 Market size analysis, By Distribution Channel, 2020-2027
9.3.4.4 Market size analysis, By Atrial Fibrillation Type, 2020-2027
9.3.5 South Korea
9.3.5.1 Market size analysis, By Product, 2020-2027
9.3.5.2 Market size analysis, By Technology, 2020-2027
9.3.5.3 Market size analysis, By Distribution Channel, 2020-2027
9.3.5.4 Market size analysis, By Atrial Fibrillation Type, 2020-2027
9.3.6 Rest of Asia-Pacific
9.3.6.1 Market size analysis, By Product, 2020-2027
9.3.6.2 Market size analysis, By Technology, 2020-2027
9.3.6.3 Market size analysis, By Distribution Channel, 2020-2027
9.3.6.4 Market size analysis, By Atrial Fibrillation Type, 2020-2027
9.3.7 Research Dive Exclusive Insights
9.3.7.1 Market attractiveness
9.3.7.2 Competition heatmap
9.4 LAMEA
9.4.1 Brazil
9.4.1.1 Market size analysis, By Product, 2020-2027
9.4.1.2 Market size analysis, By Technology, 2020-2027
9.4.1.3 Market size analysis, By Distribution Channel, 2020-2027
9.4.1.4 Market size analysis, By Atrial Fibrillation Type, 2020-2027
9.4.2 Saudi Arabia
9.4.2.1 Market size analysis, By Product, 2020-2027
9.4.2.2 Market size analysis, By Technology, 2020-2027
9.4.2.3 Market size analysis, By Distribution Channel, 2020-2027
9.4.2.4 Market size analysis, By Atrial Fibrillation Type, 2020-2027
9.4.3 UAE
9.4.3.1 Market size analysis, By Product, 2020-2027
9.4.3.2 Market size analysis, By Technology, 2020-2027
9.4.3.3 Market size analysis, By Distribution Channel, 2020-2027
9.4.3.4 Market size analysis, By Atrial Fibrillation Type, 2020-2027
9.4.4 South Africa
9.4.4.1 Market size analysis, By Product, 2020-2027
9.4.4.2 Market size analysis, By Technology, 2020-2027
9.4.4.3 Market size analysis, By Distribution Channel, 2020-2027
9.4.4.4 Market size analysis, By Atrial Fibrillation Type, 2020-2027
9.4.5 Rest of LAMEA
9.4.5.1 Market size analysis, By Product, 2020-2027
9.4.5.2 Market size analysis, By Technology, 2020-2027
9.4.5.3 Market size analysis, By Distribution Channel, 2020-2027
9.4.5.4 Market size analysis, By Atrial Fibrillation Type, 2020-2027
9.4.6 Research Dive Exclusive Insights
9.4.6.1 Market attractiveness
9.4.6.2 Competition heatmap
10. Competitive Landscape
10.1 Top winning strategies, 2020-2027
10.1.1 By strategy
10.1.2 By year
10.2 Strategic overview
10.3 Market share analysis, 2020-2027
11. Company Profiles
11.1 Macrogen, Inc.
11.1.1 Overview
11.1.2 Business segments
11.1.3 Product portfolio
11.1.4 Financial performance
11.1.5 Recent developments
11.1.6 SWOT analysis
11.2 Ambry Genetics
11.2.1 Overview
11.2.2 Business segments
11.2.3 Product portfolio
11.2.4 Financial performance
11.2.5 Recent developments
11.2.6 SWOT analysis
11.3 Illumina
11.3.1 Overview
11.3.2 Business segments
11.3.3 Product portfolio
11.3.4 Financial performance
11.3.5 Recent developments
11.3.6 SWOT analysis
11.4 Inc.
11.4.1 Overview
11.4.2 Business segments
11.4.3 Product portfolio
11.4.4 Financial performance
11.4.5 Recent developments
11.4.6 SWOT analysis
11.5 Knome, Inc.
11.5.1 Overview
11.5.2 Business segments
11.5.3 Product portfolio
11.5.4 Financial performance
11.5.5 Recent developments
11.5.6 SWOT analysis
11.6 Life Technologies
11.6.1 Overview
11.6.2 Business segments
11.6.3 Product portfolio
11.6.4 Financial performance
11.6.5 Recent developments
11.6.6 SWOT analysis
11.7 Agilent Technologies
11.7.1 Overview
11.7.2 Business segments
11.7.3 Product portfolio
11.7.4 Financial performance
11.7.5 Recent developments
11.7.6 SWOT analysis
11.8 Roche NimbleGen, Inc.
11.8.1 Overview
11.8.2 Business segments
11.8.3 Product portfolio
11.8.4 Financial performance
11.8.5 Recent developments
11.8.6 SWOT analysis
11.9 Sengenics
11.9.1 Overview
11.9.2 Business segments
11.9.3 Product portfolio
11.9.4 Financial performance
11.9.5 Recent developments
11.9.6 SWOT analysis
11.10 GENEWIZ, Inc.
11.10.1 Overview
11.10.2 Business segments
11.10.3 Product portfolio
11.10.4 Financial performance
11.10.5 Recent developments
11.10.6 SWOT analysis
11.11 Eurofins Genomics
11.11.1 Overview
11.11.2 Business segments
11.11.3 Product portfolio
11.11.4 Financial performance
11.11.5 Recent developments
11.11.6 SWOT analysis
11.12 Inc.
11.12.1 Overview
11.12.2 Business segments
11.12.3 Product portfolio
11.12.4 Financial performance
11.12.5 Recent developments
11.12.6 SWOT analysis
11.13 BGI
11.13.1 Overview
11.13.2 Business segments
11.13.3 Product portfolio
11.13.4 Financial performance
11.13.5 Recent developments
11.13.6 SWOT analysis
Personalize this research
- Triangulate with your own data
- Request your format and definition
- Get a deeper dive on a specific application, geography, customer or competitor
- + 1-888-961-4454 Toll - Free
- support@researchdive.com
